BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3915179)

  • 1. Opsonization of group B streptococci in properdin deficient serum.
    Söderström C; Braconier JH; Christensen KK; Christensen P; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand C; 1985 Dec; 93(6):251-6. PubMed ID: 3915179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.
    Braconier JH; Odeberg H; Sjöholm AG
    Infect Immun; 1983 Apr; 40(1):219-24. PubMed ID: 6403465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.
    Söderström C; Braconier JH; Käyhty H; Sjöholm AG; Thuresson B
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):220-4. PubMed ID: 2496990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
    Giebink GS; Verhoef J; Peterson PK; Quie PG
    Infect Immun; 1977 Nov; 18(2):291-7. PubMed ID: 21849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
    Fischer GW; Hunter KW; Wilson SR
    Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.
    Levy NJ; Kasper DL
    Infect Immun; 1985 Jul; 49(1):19-24. PubMed ID: 3891622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired opsonophagocytosis of serotypes Ib and II of group B streptococci as compared with serotypes Ia and III: role of the alternative pathway of complement in opsonisation of serotype III of group B streptococci.
    Hindocha P; Hill R; Wood CB; Patel U; Hunt G
    J Clin Pathol; 1984 Jul; 37(7):790-5. PubMed ID: 6378978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
    Dale JB; Washburn RG; Marques MB; Wessels MR
    Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ingestion and killing of Streptococcus agalactiae by bovine granulocytes in the presence of natural opsonins.
    Rainard P; Lautrou Y; Poutrel B
    Vet Microbiol; 1988 Sep; 18(1):41-50. PubMed ID: 3055659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antibody and complement in opsonization of group B streptococci.
    Shigeoka AO; Hall RT; Hemming VG; Allred CD; Hill HR
    Infect Immun; 1978 Jul; 21(1):34-40. PubMed ID: 101462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to the group B streptococci: interaction of serum and macrophages with types Ia, Ib, and Ic.
    Anthony BF
    J Exp Med; 1976 May; 143(5):1186-98. PubMed ID: 772153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luminol-enhanced chemiluminescence for evaluation of type III group B streptococcal opsonins in human sera.
    Anderson DC; Edwards MS; Baker CJ
    J Infect Dis; 1980 Mar; 141(3):370-81. PubMed ID: 6988524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte functions and Neisseria meningitidis: influence of properdin-deficient serum.
    Söderström C; Braconier JH; Sjöholm AG; Thuresson B
    APMIS; 1991 Nov; 99(11):965-71. PubMed ID: 1958352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic specificity of opsonophagocytic antibodies in rabbit anti-sera to group B streptococci.
    Baltimore RS; Kasper DL; Baker CJ; Goroff DK
    J Immunol; 1977 Feb; 118(2):673-8. PubMed ID: 65433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in the opsonic requirements of group B streptococcus type III.
    Hastings MJ; Easmon CS
    Br J Exp Pathol; 1981 Oct; 62(5):519-25. PubMed ID: 7028075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.
    Rainard P; Boulard C
    Infect Immun; 1992 Nov; 60(11):4801-8. PubMed ID: 1398991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepancy between effects of in vivo and in vitro administration of gammaglobulin on phagocytic killing of Streptococcus pneumoniae in an antibody-deficient serum.
    Braconier JH; Prellner K; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1988; 86(4):426-31. PubMed ID: 2457557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.